Vyant Bio's total assets is $15M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Vyant Bio (VYNT) currently reports a total assets of $15M as of December 2022. That compares with $38M in the prior-year period — down 59.6% year over year. Use the charts on this page to explore Vyant Bio's total assets history and peer comparisons.
Vyant Bio's total assets decreased from $38M to $15M — a 59.6% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Vyant Bio reported $15M in total assets as of December 2022. That compares with $38M in the prior-year period — down 59.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total assets of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vyant Bio, and consider following VYNT for alerts when major investors trade the stock.
Vyant Bio is classified in the Healthcare sector. On total assets, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VYNT with unrelated industries.